References
- Roudabush FL, Pierce KL, Maudsley S, et al. Transactivation of the EGF receptor mediates IGF-1-stimulated Shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 2000; 275:22583–9
- Cruzalegui FH, Cano E, Treisman R. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry. Oncogene 1999;18: 7948–57
- Boulton TG, Nye SH, Robbins DJ, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991;65:663–75
- Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268: 14553–6
- Alvarez E, Northwood IC, Gonzalez FA, et al. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem 1991;266: 15277–85
- Arteaga CL, Johnson MD, Todderud G, et al. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci 1991;88:10435–9
- Seger R, Krebs EG. The MAPK signaling cascade. FASEBJ 1995;9:726–35
- Oka H, Chatani Y, Hoshino R, et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995;55:4182–7
- Janes PW, Daly RJ, deFazio A, et al. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994;9: 3601–8
- Mansour SJ, Matten WT, Hermann AS, et al. Trans-formation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966–70
- Clark GJ, Der CJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 1995;35:133–44
- Kenney NJ, Dickson RB. Growth factor and sex steroid interactions in breast cancer. JMammary Gland Biol Neoplasia 1996;1:189–98
- Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci 1994;91: 8517–21
- Migliaccio A, Di Domenico M, Castoria G, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activ-ation by estradiol-receptor complex in MCF-7 cells. EMBOJ 1996;15:1292–300
- Gentry MK, Dalrymple JM. Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol 1980;12:361–6
- Meirik O, Lund E, Adami HO, et al. Oral contra-ceptives and breast cancer. Lancet 1986;2:1272–3
- Qiu RG, Chen J, Kim D, et al. An essential role for Rac in Ras transformation. Nature 1995;374:457–9
- Migliaccio A, Di Domenico M, Castoria G, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBOJ 1996;15:1292–300
- Bunone G, Briand PA, Miksicek RJ, et al. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBOJ 1996;15:2174–83
- Iacopino F, Ferrandina G, Scambia G, et al. Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells. Anticancer Res 1996;16:1919–24
- Kasid A, Lippman ME. Estrogen and oncogene mediated growth regulation of human breast cancer cells. J Steroid Biochem 1987;27:465–70
- Jordan VC (ed). Estrogen-Antiestrogen Action and Breast Cancer Therapy. Madison: University of Wisconsin Press, 1986:132–43
- Santen RJ, Manni A, Harvey H, et al. Endocrine treatment of breast cancer in women. Endocr Rev 1990;11:221–65
- Endoh H, Sasaki H, Maruyama K, et al. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 1997;235: 99–102
- Watters JJ, Campbell JS, Cunningham MJ, etal. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 1997;138:4030–3